Scalpel Weekly News

Week of: May 06, 2013

IN THE NEWS


Anti-seizure Drug Potiga Linked to Retinal Abnormalities and Blue Skin Discoloration

The FDA is warning the public that the anti-seizure medication Potiga (ezogabine) can cause blue skin discoloration and eye abnormalities characterized by pigment changes in the retina. The FDA does not currently know if these changes are reversible. Click title to continue reading...


 
MEDICAL ALERTS


FDA Approves Kcentra for Urgent Reversal of Anticoagulation in Adults with Major Bleeding

The FDA approved Kcentra (Prothrombin Complex Concentrate, Human) for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding. Plasma is the only other product approved for this use in the United States. Click title to continue reading...



Zilver PTX Drug Eluting Stent Subject to Global Recall Due to Potential for Delivery System Catheter Separation; Potential for Serious Injury

Based on complaints that the delivery system of the device had separated at the tip of the inner catheter, Cook Medical has recalled its Zilver PTX Drug Eluting Peripheral Stent. Two adverse events, including one death, occurred in cases where a tip separation was reported. Click title to continue reading...



NIOSH Recommends New Exposure Levels for Nanomaterials to Reduce Worker’s Risk of Lung Damage

The CDC’s National Institute for Occupational Safety and Health (NIOSH) recommended that occupational exposures to carbon nanotubes and nanofibers be controlled to reduce worker’s potential risk for certain work-related lung effects. NIOSH is the first federal agency to issue recommended exposure levels for this growing industry. Click title to continue reading...


  CASE ALERTS


US Files False Claims Complaint Against Novartis Regarding Doctor Kickback Payments For Prescribing Its Drugs

The Justice Department announced today that the United States has filed a second civil false claims lawsuit against Novartis Pharmaceuticals Corp. involving alleged kickbacks paid by the company to health care providers. The government’s complaint seeks damages and civil penalties under the False Claims Act and under the common law for paying kickbacks to doctors to induce them to prescribe Novartis pharmaceutical products that were reimbursed by federal health care programs. Click title to continue reading...



Plaintiff's Counsel's Prejudicial Comments and Arguments that Damages Should Represent Value of a Human Life Mandated Reversal and New Trial

A woman was admitted to a hospital with complaints of confusion, decreased appetite, and tremors, and also had end-stage renal disease, respiratory failure, pneumonia, and had been on dialysis. An immediate concern was probable sepsis from the dialysis catheter. This was the only access her doctors had to conduct dialysis. Click title to continue reading...



Nebraska Physical Therapists’ Professional Services Subject to Two-Year Statute of Limitations Applicable to Professional Negligence Suits

A woman underwent doctor-prescribed aquatic physical therapy. A physical therapist, that provided therapy to the patient, evaluated her ability to walk and to go up and down steps, and determined she did not have trouble walking. Click title to continue reading...